ABI-4334

ABI-4334 · Assembly Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-4334, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection [Phase 1]

See pricing